基本信息
浏览量:147
职业迁徙
个人简介
Tanya Barauskas Dorff, M.D., is an associate clinical professor in the Department of Medical Oncology & Therapeutics Research and serves as head of the genitourinary cancers program at City of Hope. She is an internationally recognized leader in prostate cancer, and is renowned for her work in other genitourinary tumor types, including kidney, bladder and penile cancer.
Dr. Dorff graduated summa cum laude from the University of Houston before attending the UCLA School of Medicine. There, she was inducted into the prestigious Alpha Omega Alpha honors society. She subsequently completed her internal medicine residency at Mt. Sinai Hospital in New York, and finished subspecialty training in hematology and oncology at Los Angeles County + USC Medical Center.
Dr. Dorff was on the faculty at USC for nearly 10 years, eventually amassing over 70 publications in top-tier journals, including Cancer, Lancet Oncology and Journal of Clinical Oncology. She has been invited to speak at multiple national and international meetings, and serves on the NCCN Prostate Cancer Guidelines Committee and the National Cancer Institute Prostate Cancer Task Force.
Dr. Dorff’s research interests in prostate cancer are wide ranging. In the area of clinical trials, she is heavily involved in the design and conduct of trials with immunotherapy and exploring treatment combinations. She has also worked on trials examining lifestyle (supplements, exercise) and treatment side effects (cognitive function).
Dr. Dorff leads City of Hope’s joint effort with the Prostate Cancer Foundation to develop novel immune-based strategies for prostate cancer. Specifically, she leads an effort to develop chimeric antigen receptor (CAR) T cells – cells that are primed to target prostate cancer tissue. These strategies have been transformative in certain blood-based cancers. She is also engaging with TGEN scientists Muhammad Murtaza, and Sarah Highlander, Ph.D., to investigate ctDNA as a biomarker and the role of the microbiome in earlier stage disease.
Dr. Dorff graduated summa cum laude from the University of Houston before attending the UCLA School of Medicine. There, she was inducted into the prestigious Alpha Omega Alpha honors society. She subsequently completed her internal medicine residency at Mt. Sinai Hospital in New York, and finished subspecialty training in hematology and oncology at Los Angeles County + USC Medical Center.
Dr. Dorff was on the faculty at USC for nearly 10 years, eventually amassing over 70 publications in top-tier journals, including Cancer, Lancet Oncology and Journal of Clinical Oncology. She has been invited to speak at multiple national and international meetings, and serves on the NCCN Prostate Cancer Guidelines Committee and the National Cancer Institute Prostate Cancer Task Force.
Dr. Dorff’s research interests in prostate cancer are wide ranging. In the area of clinical trials, she is heavily involved in the design and conduct of trials with immunotherapy and exploring treatment combinations. She has also worked on trials examining lifestyle (supplements, exercise) and treatment side effects (cognitive function).
Dr. Dorff leads City of Hope’s joint effort with the Prostate Cancer Foundation to develop novel immune-based strategies for prostate cancer. Specifically, she leads an effort to develop chimeric antigen receptor (CAR) T cells – cells that are primed to target prostate cancer tissue. These strategies have been transformative in certain blood-based cancers. She is also engaging with TGEN scientists Muhammad Murtaza, and Sarah Highlander, Ph.D., to investigate ctDNA as a biomarker and the role of the microbiome in earlier stage disease.
研究兴趣
论文共 333 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Zeynep B. Zengin,Nicholas C. Henderson,Joseph J. Park,Alicia Ali, Charles Nguyen,Clara Hwang,Pedro C. Barata,Mehmet A. Bilen,Laura Graham, George Mo,Deepak Kilari,Abhishek Tripathi,
Research squarepp.1-7, (2024)
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meetingno. 2 (2024): e430428-e430428
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 6 (2024): 1111-1120
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2301157-JCO2301157, (2024)
Matthew D. Galsky,Siamak Daneshmand,Sudeh Izadmehr,Edgar Gonzalez-Kozlova,Kevin G. Chan,Sara Lewis, Bassam El Achkar,Tanya B. Dorff,Jeremy Paul Cetnar,Brock O. Neil, Anishka D’Souza,Ronac Mamtani,
Nature medicineno. 11 (2024): 1-1
Urologic Oncology: Seminars and Original Investigations (2024)
Tanya Barauskas Dorff, Alan H Bryce
Cancer (2024)
Rahul Aggarwal,Scott E. Eggener,Glenn Heller, Habn Xiao,David W. Hillman,Joel Picus, Jennifer Wang,Mary Ellen Taplin,Tanya B. Dorff,Leonard Joseph Appleman, Doug Weckstein,Akash Patnaik,
The Journal of Urologyno. Supplement 4 (2023)
引用0浏览0引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 5074-5074
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn